These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 16298255)
21. Chronic kidney disease: the new silent killer. Kopyt NP J Am Osteopath Assoc; 2006 Mar; 106(3):133-6. PubMed ID: 16585380 [No Abstract] [Full Text] [Related]
22. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients. Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403 [TBL] [Abstract][Full Text] [Related]
23. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality. Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213 [TBL] [Abstract][Full Text] [Related]
24. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients. Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485 [TBL] [Abstract][Full Text] [Related]
25. An analysis of cardiac mortality in patients with new-onset end-stage renal disease in New York State. Wallen MD; Radhakrishnan J; Appel G; Hodgson ME; Pablos-Mendez A Clin Nephrol; 2001 Feb; 55(2):101-8. PubMed ID: 11269672 [TBL] [Abstract][Full Text] [Related]
26. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients. Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121 [TBL] [Abstract][Full Text] [Related]
27. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473 [TBL] [Abstract][Full Text] [Related]
28. Predictive role of BNP and NT-proBNP in hemodialysis patients. Sun L; Sun Y; Zhao X; Xu C; Chen D; Li L; Ma Y; Rong S; Mei C Nephron Clin Pract; 2008; 110(3):c178-84. PubMed ID: 18957868 [TBL] [Abstract][Full Text] [Related]
29. [Cardioprotection: an essential component for predialysis chronic renal failure treatment]. Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513 [TBL] [Abstract][Full Text] [Related]
30. Heart rate as independent prognostic factor for mortality in normotensive hemodialysed patients. Cice G; Di Benedetto A; D'Andrea A; D'Isa S; De Gregorio P; Marcelli D; Gatti E; Calabrò R J Nephrol; 2008; 21(5):704-12. PubMed ID: 18949725 [TBL] [Abstract][Full Text] [Related]
31. Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease? Rubin C; Nolin TD; Himmelfarb J Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):506-11. PubMed ID: 18089962 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E; J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211 [TBL] [Abstract][Full Text] [Related]
33. Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Kovesdy CP; Trivedi BK; Kalantar-Zadeh K; Anderson JE Nephrol Dial Transplant; 2006 May; 21(5):1257-62. PubMed ID: 16421161 [TBL] [Abstract][Full Text] [Related]
34. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. de Mutsert R; Grootendorst DC; Axelsson J; Boeschoten EW; Krediet RT; Dekker FW; Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817 [TBL] [Abstract][Full Text] [Related]
35. Gender-dependent impact of risk factors for cardiovascular and non-cardiovascular mortality in end-stage renal disease patients on haemodialysis. Hocher B; Kalk P; Godes M; Liefeldt L; Ziebig R; Stasch JP; Quaschning T; Pfab T Kidney Blood Press Res; 2008; 31(5):360-6. PubMed ID: 19023219 [TBL] [Abstract][Full Text] [Related]
36. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients]. Grabysa R; Cholewa M Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327 [TBL] [Abstract][Full Text] [Related]
37. The evaluation incidence and risk factors of mortality among patients with end stage renal disease in southeast Turkey. Sit D; Kadiroglu AK; Kayabasi H; Kara IH; Yilmaz Z; Yilmaz ME Ren Fail; 2008; 30(1):37-44. PubMed ID: 18197541 [TBL] [Abstract][Full Text] [Related]
38. Familiality of cardiovascular mortality in end-stage renal disease patients. Naiman N; Cheung AK; Goldfarb-Rumyantzev AS Am J Nephrol; 2009; 29(3):237-43. PubMed ID: 18799871 [TBL] [Abstract][Full Text] [Related]
39. Arterial wave reflections and mortality in haemodialysis patients--only relevant in elderly, cardiovascularly compromised? Covic A; Mardare N; Gusbeth-Tatomir P; Prisada O; Sascau R; Goldsmith DJ Nephrol Dial Transplant; 2006 Oct; 21(10):2859-66. PubMed ID: 16854850 [TBL] [Abstract][Full Text] [Related]
40. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]